litlas
Log inCreate account

Harry W. Herr

Active 1981–2025

Also published as
HARRY W. HERR
162
Papers
34,229
Citations
108
h-index
161
i10-index

Citations

Citations per year for Harry W. Herr1956: 1 citations1982: 1 citations1983: 5 citations1984: 1 citations1985: 15 citations1986: 19 citations1987: 28 citations1988: 23 citations1989: 28 citations1990: 34 citations1991: 31 citations1992: 25 citations1993: 34 citations1994: 36 citations1995: 58 citations1996: 48 citations1997: 83 citations1998: 72 citations1999: 76 citations2000: 108 citations2001: 117 citations2002: 122 citations2003: 180 citations2004: 149 citations2005: 182 citations2006: 188 citations2007: 203 citations2008: 165 citations2009: 214 citations2010: 184 citations2011: 211 citations2012: 226 citations2013: 199 citations2014: 150 citations2015: 125 citations2016: 155 citations2017: 147 citations2018: 170 citations2019: 633 citations2020: 665 citations2021: 472 citations2022: 349 citations2023: 275 citations2024: 484 citations2025: 226 citations2026: 8 citations1957–1981: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,287 citing papers, 27.1% of this breakdownItaly: 587 citing papers, 6.9% of this breakdownChina: 569 citing papers, 6.7% of this breakdownGermany: 527 citing papers, 6.2% of this breakdownCanada: 444 citing papers, 5.3% of this breakdownUnited Kingdom: 430 citing papers, 5.1% of this breakdownFrance: 353 citing papers, 4.2% of this breakdownSpain: 308 citing papers, 3.6% of this breakdownJapan: 290 citing papers, 3.4% of this breakdownNetherlands: 282 citing papers, 3.3% of this breakdownAustria: 259 citing papers, 3.1% of this breakdownSwitzerland: 182 citing papers, 2.2% of this breakdown
0%27.1%Other 22.9%

Institutions

Fields

  • Medicine86.7%
  • Biochemistry, Genetics and Molecular Biology7.9%
  • Immunology and Microbiology2%
  • Computer Science0.8%
  • Engineering0.5%
  • Health Professions0.3%
  • Other1.8%

Topics

  • Bladder and Urothelial Cancer Treatments21.8%
  • Urinary and Genital Oncology Studies13.3%
  • Cancer Immunotherapy and Biomarkers2.9%
  • Urinary Tract Infections Management2.8%
  • Renal cell carcinoma treatment2.4%
  • Prostate Cancer Diagnosis and Treatment2.3%
  • Other54.5%

Coauthors

All papers

Open in search
  1. NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022

    Authors: Thomas W. Flaig, Philippe E. Spiess, Michael Abern, Neeraj Agarwal, Rick Bangs, Stephen A. Boorjian, Mark K. Buyyounouski, Kevin Chan, Sam S. Chang, Terence W. Friedlander, Richard E. Greenberg, Khurshid A. Guru, Harry W. Herr, Jean Hoffman‐Censits, Amar U. Kishan, Shilajit Kundu, Subodh M. Lele, Ronac Mamtani, Vitaly Margulis, Omar Y. Mian, Jeff M. Michalski, Jeffrey S. Montgomery, Lakshminarayanan Nandagopal, Lance C. Pagliaro, Mamta Parikh, Anthony Patterson, Elizabeth R. Plimack, Kamal S. Pohar, Mark A. Preston, Kyle A. Richards, Wade J. Sexton, Arlene O. Siefker‐Radtke, Matthew K. Tollefson, Jonathan D. Tward, Jonathan L. Wright, Mary A. Dwyer, Carly J. Cassara, Lisa A. Gurski - Journal of the National Comprehensive Cancer Network 2022 cited by 302

  2. Epidemiology and Risk Factors of Urothelial Bladder Cancer

    Authors: Maximilian Burger, James W.F. Catto, Guido Dalbagni, H. Barton Grossman, Harry W. Herr, Pierre I. Karakiewicz, Wassim Kassouf, Lambertus A. Kiemeney, Carlo La Vecchia, Shahrokh F. Shariat, Yair Lotan - European Urology 2012 cited by 2,187

  3. Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology

    Authors: Thomas W. Flaig, Philippe E. Spiess, Neeraj Agarwal, Rick Bangs, Stephen A. Boorjian, Mark K. Buyyounouski, Sam S. Chang, Tracy M. Downs, Jason A. Efstathiou, Terence W. Friedlander, Richard E. Greenberg, Khurshid A. Guru, Thomas Guzzo, Harry W. Herr, Jean Hoffman‐Censits, Christopher Hoimes, Brant A. Inman, Masahito Jimbo, A. Karim Kader, Subodh M. Lele, Jeff M. Michalski, Jeffrey S. Montgomery, Lakshminarayanan Nandagopal, Lance C. Pagliaro, Sumanta K. Pal, Anthony Patterson, Elizabeth R. Plimack, Kamal S. Pohar, Mark A. Preston, Wade J. Sexton, Arlene O. Siefker‐Radtke, Jonathan D. Tward, Jonathan L. Wright, Lisa A. Gurski, Alyse Johnson-Chilla - Journal of the National Comprehensive Cancer Network 2020 cited by 628

  4. Bladder Cancer, Version 3.2024

    Authors: Thomas W. Flaig, Philippe E. Spiess, Michael Abern, Neeraj Agarwal, Rick Bangs, Mark K. Buyyounouski, Kevin Chan, Sam S. Chang, Paul Chang, Terence W. Friedlander, Richard E. Greenberg, Khurshid A. Guru, Harry W. Herr, Jean Hoffman‐Censits, Hristos Z. Kaimakliotis, Amar U. Kishan, Shilajit Kundu, Subodh M. Lele, Ronac Mamtani, Omar Y. Mian, Jeff M. Michalski, Jeffrey S. Montgomery, Mamta Parikh, Anthony Patterson, Charles C. Peyton, Elizabeth R. Plimack, Mark A. Preston, Kyle A. Richards, Wade J. Sexton, Arlene O. Siefker‐Radtke, Tyler F. Stewart, Debasish Sundi, Matthew K. Tollefson, Jonathan D. Tward, Jonathan L. Wright, Carly J. Cassara, Lisa A. Gurski - Journal of the National Comprehensive Cancer Network 2024 cited by 236

  5. Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting Methodology

    Authors: Ahmad Shabsigh, Ruslan Korets, Kinjal Vora, Christine Brooks, Angel M. Cronin, Caroline Savage, Ganesh V. Raj, Bernard H. Bochner, Guido Dalbagni, Harry W. Herr, S. Machele Donat - European Urology 2008 cited by 1,399

  6. Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma

    Authors: Jonathan Coleman, Wesley Yip, Nathan C. Wong, Daniel D. Sjoberg, Bernard H. Bochner, Guido Dalbagni, S. Machele Donat, Harry W. Herr, K. Eugene, Timothy F. Donahue, Eugene J. Pietzak, A. Ari Hakimi, Kwanghee Kim, Hikmat Al‐Ahmadie, H. Alberto Vargas, Ricardo Alvim, Soleen Ghafoor, Nicole Benfante, Anoop Meraney, Steven J. Shichman, Jeffrey M. Kamradt, Suresh Nair, Angelo A. Baccala, Paul Palyca, Bradley W. Lash, Muhammad A. Rizvi, Scott K. Swanson, Antonio F Muina, Andrea B. Apolo, Gopa Iyer, Jonathan E. Rosenberg, Min Yuen Teo, Dean F. Bajorin - Journal of Clinical Oncology 2023 cited by 105

  7. Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial

    Authors: Samuel A. Funt, Michael Lattanzi, Karissa Whiting, Hikmat Al‐Ahmadie, Colleen Quinlan, Min Yuen Teo, Chung‐Han Lee, David H. Aggen, Danielle Elise Zimmerman, Deaglan Joseph McHugh, Arlyn Apollo, Trey Durdin, Hong Truong, Jeffrey M. Kamradt, Maged Khalil, Bradley W. Lash, Irina Ostrovnaya, Asia S. McCoy, Grace Hettich, Ashley Marie Regazzi, Marwah Jihad, Neha Ratna, Abigail Boswell, Kaitlyn Francese, Yuanquan Yang, Edmund Folefac, Harry W. Herr, S. Machele Donat, Eugene J. Pietzak, K. Eugene, Timothy F. Donahue, Alvin C. Goh, William C. Huang, Dean F. Bajorin, Gopa Iyer, Bernard H. Bochner, Arjun Vasant Balar, Amir Mortazavi, Jonathan E. Rosenberg - Journal of Clinical Oncology 2022 cited by 99

  8. Age‐adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer

    Authors: Theresa M. Koppie, Angel M. Serio, Andrew J. Vickers, Kinjal Vora, Guido Dalbagni, S. Machele Donat, Harry W. Herr, Bernard H. Bochner - Cancer 2008 cited by 357

  9. Health-related Quality of Life for Patients Undergoing Radical Cystectomy: Results of a Large Prospective Cohort

    Authors: Matthew Clements, Thomas M. Atkinson, Guido Dalbagni, Yuelin Li, Andrew J. Vickers, Harry W. Herr, S. Machele Donat, Jaspreet S. Sandhu, Daniel Sjöberg, Amy L. Tin, Bruce D. Rapkin, Bernard H. Bochner - European Urology 2021 cited by 102

  10. Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial

    Authors: Bernard H. Bochner, Guido Dalbagni, Daniel D. Sjoberg, Jonathan Silberstein, Gal E. Keren Paz, S. Machele Donat, Jonathan Coleman, Sheila Mathew, Andrew J. Vickers, Geoffrey Schnorr, Michael Feuerstein, Bruce D. Rapkin, Raul O. Parra, Harry W. Herr, Vincent P. Laudone - European Urology 2014 cited by 597

  11. Long-Term Survival in Metastatic Transitional-Cell Carcinoma and Prognostic Factors Predicting Outcome of Therapy

    Authors: Dean F. Bajorin, Paul M. Dodd, Madhu Mazumdar, Melissa Fazzari, John A. McCaffrey, Howard I. Scher, Harry W. Herr, Geralyn Higgins, Mary G. Boyle - Journal of Clinical Oncology 1999 cited by 729

  12. EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†

    Authors: J. Alfred Witjes, Marek Babjuk, Joaquim Bellmunt, H.M. Bruins, Theo M. de Reijke, Maria De Santis, Silke Gillessen, Nicholas D. James, Steven MacLennan, Juan Palou, Tom Powles, María J. Ribal, Shahrokh F. Shariat, Theodorus van der Kwast, Évanguelos Xylinas, Neeraj Agarwal, Tom J.H. Arends, Aristotle Bamias, Alison Birtle, Peter C. Black, Bernard H. Bochner, M. Bolla, Joost L. Boormans, Alberto Bossi, Alberto Briganti, Iris Brummelhuis, Max M. Burger, Daniel Castellano, Richard Cathomas, Arturo Chiti, Ananya Choudhury, Éva Compérat, Simon J. Crabb, Stéphane Culine, Berardino De Bari, Willem de Blok, Pieter De Visschere, Karel Decaestecker, Konstantinos Dimitropoulos, José L. Domínguez-Escrig, Stefano Fanti, Valérie Fonteyne, Mark Frydenberg, Jurgen J. Fütterer, Georgios Gakis, Bogdan Geavlete, Paolo Gontero, Bernhard Grubmüller, S. Hafeez, Donna E. Hansel, Arndt Hartmann, Dickon Hayne, Ann Henry, Virginia Hernández, Harry W. Herr, Ken Herrmann, Peter Hoskin, J. Huguet, Barbara Alicja Jereczek‐Fossa, Rob Jones, Ashish M. Kamat, Vincent Khoo, Anne E. Kiltie, S. Krege, Sylvain Ladoire, Pedro C. Lara, Anna M. Leliveld, Estefanía Linares-Espinós, Vibeke Løgager, Anja Lorch, Yohann Loriot, Richard P. Meijer, Maria Carmen Mir, Marco Moschini, Hugh Mostafid, Arndt‐Christian Müller, Christoph R. Müller, James N’Dow, Andrea Necchi, Y. Neuzillet, Jorg R. Oddens, Jan Oldenburg, Susanne Osanto, Wim J.G. Oyen, Luís Pacheco‐Figueiredo, Helle Pappot, Manish I. Patel, Bradley R. Pieters, Karin Plass, Mesut Remzi, Margitta Retz, Jonathan Richenberg, Michael Rink, Florian Roghmann, Jonathan E. Rosenberg, Morgan Rouprêt, Olivier Rouvière, Carl Salembier, Antti Salminen, Paul Sargos and 21 more - European Urology 2019 cited by 192

  13. Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic Review

    Authors: Guillaume Ploussard, Siamak Daneshmand, Jason A. Efstathiou, Harry W. Herr, Nicholas D. James, Claus Rödel, Shahrokh F. Shariat, William U. Shipley, Cora N. Sternberg, George N. Thalmann, Wassim Kassouf - European Urology 2014 cited by 358

  14. History of Bacillus Calmette-Guerin and Bladder Cancer: An Immunotherapy Success Story

    Authors: Harry W. Herr, Álvaro Morales - The Journal of Urology 2007 cited by 355

  15. CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma

    Authors: Padmanee Sharma, Yu Shen, Sijin Wen, Sachiko Yamada, Achim A. Jungbluth, Sacha Gnjatic, Dean F. Bajorin, Victor E. Reuter, Harry W. Herr, Lloyd J. Old, Eiichi Sato - National Academy of Sciences, Proceedings of the National Academy of Sciences 2007 cited by 517

  16. Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes

    Authors: Bernard H. Bochner, Guido Dalbagni, Karim Marzouk, Daniel D. Sjoberg, Justin Lee, Sheri M. Donat, Jonathan Coleman, Andrew J. Vickers, Harry W. Herr, Vincent P. Laudone - European Urology 2018 cited by 267

  17. Penile Cancer

    Authors: Peter E. Clark, Philippe E. Spiess, Neeraj Agarwal, Matthew C. Biagioli, Mario A. Eisenberger, Richard E. Greenberg, Harry W. Herr, Brant A. Inman, Deborah A. Kuban, Timothy M. Kuzel, Subodh M. Lele, Jeff M. Michalski, Lance C. Pagliaro, Sumanta K. Pal, Anthony Patterson, Elizabeth R. Plimack, Kamal S. Pohar, Michael P. Porter, Jerome P. Richie, Wade J. Sexton, William U. Shipley, Eric J. Small, Donald L. Trump, Geoffrey Wile, Timothy G. Wilson, Mary A. Dwyer, Maria Ho - Journal of the National Comprehensive Cancer Network 2013 cited by 185

  18. Incidence and Treatment of Complications of Bacillus Calmette-Guerin Intravesical Therapy in Superficial Bladder Cancer

    Authors: Donald L. Lamm, A.P.M. van der Meijden, Álvaro Morales, Stanley A. Brosman, William J. Catàlona, Harry W. Herr, Mark S. Soloway, A Steg, F.M.J. Debruyne - The Journal of Urology 1992 cited by 795

  19. Genomic Differences Between “Primary” and “Secondary” Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy

    Authors: Eugene J. Pietzak, Emily C. Zabor, Aditya Bagrodia, Joshua Armenia, Wenhuo Hu, Ahmet Zehir, Samuel A. Funt, François Audenet, David Barron, Noelia Maamouri, Qiang Li, Min Yuen Teo, Maria E. Arcila, Michael F. Berger, Nikolaus Schultz, Guido Dalbagni, Harry W. Herr, Dean F. Bajorin, Jonathan E. Rosenberg, Hikmat Al‐Ahmadie, Bernard H. Bochner, David B. Solit, Gopa Iyer - European Urology 2018 cited by 152

  20. The Treated Natural History of High Risk Superficial Bladder Cancer: 15-year Outcome

    Authors: Michael S. Cookson, Harry W. Herr, Zuo‐Feng Zhang, Scott M. Soloway, Pramod C. Sogani, William R. Fair - The Journal of Urology 1997 cited by 554

  21. Conservative Management Following Complete Clinical Response to Neoadjuvant Chemotherapy of Muscle Invasive Bladder Cancer: Contemporary Outcomes of a Multi-Institutional Cohort Study

    Authors: P Mazza, George W. Moran, Gen Li, Dennis Robins, Justin T. Matulay, Harry W. Herr, G. Joel DeCastro, James M. McKiernan, Christopher B. Anderson - The Journal of Urology 2018 cited by 78

  22. Outcome of Patients Who Refuse Cystectomy after Receiving Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer

    Authors: Harry W. Herr - European Urology 2007 cited by 95

  23. Urachal Carcinoma

    Authors: Anuradha Gopalan, David S. Sharp, Samson W. Fine, Satish K. Tickoo, Harry W. Herr, Victor E. Reuter, Semra Olgac - The American Journal of Surgical Pathology 2009 cited by 280

  24. Potential Impact of Postoperative Early Complications on the Timing of Adjuvant Chemotherapy in Patients Undergoing Radical Cystectomy: A High-Volume Tertiary Cancer Center Experience

    Authors: S. Machele Donat, Ahmad Shabsigh, Caroline Savage, Angel M. Cronin, Bernard H. Bochner, Guido Dalbagni, Harry W. Herr, Matthew I. Milowsky - European Urology 2008 cited by 260